Latest Office for Life Sciences Bulletin

18 May 2020

The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS).

Medilink shares this bulletin with its members and networks, aimed to keep the life sciences sector up to date on the latest guidance whilst the UK is in the transition period and during the Coronavirus (COVID-19) outbreak.

This week’s edition includes new guidance from MHRA:

NEW – Antibody research reagent now available for COVID-19. In support of the World Health Organization’s response to COVID-19, the National Institute for Biological Standards and Control (NIBSC) has fast-tracked the development and production of an anti-SARSCoV-2 antibody research reagent. This reagent is plasma that has been treated to inactivate enveloped viruses and is derived from a donor that has recovered from COVID-19. Please see the NIBSC website for more information.

NEW – Guidance on How tests and testing kits for COVID-19 work. The different types of tests and testing kits for COVID-19, and the specifications for manufacturers. The guidance provides information for members of the public, patients, professionals and industry about
COVID-19 tests and testing kits, including how they work, the different types of tests and the specifications manufacturers need to follow.

Plus new and updated business support guidance.

Click here to read the bulletin in full.

https://www.medilinkuk.com/sites/default/files/uploads/UK-LifeScience-Industry-Magazine-advert_7.jpg